HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
91.42
+0.84 (0.93%)
May 5, 2025, 4:00 PM EDT - Market closed
HealthEquity Revenue
In the fiscal year ending January 31, 2025, HealthEquity had annual revenue of $1.20B with 20.03% growth. HealthEquity had revenue of $311.82M in the quarter ending January 31, 2025, with 18.84% growth.
Revenue (ttm)
$1.20B
Revenue Growth
+20.03%
P/S Ratio
6.62
Revenue / Employee
$384,543
Employees
3,120
Market Cap
7.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 1.20B | 200.19M | 20.03% |
| Jan 31, 2024 | 999.59M | 137.84M | 16.00% |
| Jan 31, 2023 | 861.75M | 105.19M | 13.90% |
| Jan 31, 2022 | 756.56M | 22.99M | 3.13% |
| Jan 31, 2021 | 733.57M | 201.58M | 37.89% |
| Jan 31, 2020 | Pro | Pro | Pro |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
| Jan 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Thermo Fisher Scientific | 42.90B |
HQY News
- 6 days ago - USA Today Names HealthEquity to its Top 25 Workplaces - GlobeNewsWire
- 20 days ago - HealthEquity's Expedited Claims Technology Wins Artificial Intelligence Excellence Awards - GlobeNewsWire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages HealthEquity, Inc. (HQY) Shareholders to Inquire about Securities Investigation - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating HealthEquity, Inc. (HQY) And Encourages Shareholders to Connect - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against HealthEquity, Inc. (HQY) And Encourages Shareholders to Reach Out - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against HealthEquity, Inc. (HQY) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages HealthEquity, Inc. (HQY) Stockholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against HealthEquity, Inc. (HQY) and Encourages Investors to Learn More About the Investigation - Accesswire